Company Overview - Ventas, Inc. (NYSE: VTR) is an S&P 500 company focused on creating exceptional environments for a growing aging population [4] - The company operates approximately 1,400 properties in North America and the United Kingdom, playing a vital role in the longevity economy [4] - Ventas's portfolio includes over 850 senior housing communities, outpatient medical buildings, research centers, and healthcare facilities [4] Growth Strategy - The company's growth is driven by its senior housing communities, which provide essential services to residents [4] - Ventas aims to achieve superior performance by leveraging operational expertise, data-driven insights from its Ventas OI™ platform, and strong financial relationships [4] - The commitment of Ventas's seasoned team is to help people live longer, healthier, and happier lives [4] Upcoming Earnings Release - Ventas will release its fourth quarter 2025 earnings after the close of trading on February 5, 2026 [1] - A conference call to discuss the earnings will take place on February 6, 2026, at 10:00 a.m. Eastern Time [1]

Demographics & Technology Adoption - Younger boomers are adopting digital convenience into retirement [1] - This adoption is reshaping the longevity economy [1] Economic Impact - The shift is driven by carrying "life-by-app" into retirement [1]

Demographics & Technology Adoption - Younger boomers are adopting digital convenience into retirement [1] - This adoption is reshaping the longevity economy [1] Industry Impact - The trend involves carrying "life-by-app" into retirement [1]

Financial Data and Key Metrics Changes - The total revenue for Q2 2025 was 6,000 million baht, representing a decline of 3.6% year-over-year [26][27] - EBITDA margin reached a record high of 41.6%, while net profit margin was 30.4%, slightly up from 30.5% in the previous year [9][33] - EPS was reported at 40 baht, with a dividend payout ratio of 44% for the interim dividend, up from 41% the previous year [13] Business Line Data and Key Metrics Changes - Revenue from non-Thai patients decreased by 6.6%, while Thai patient revenue slightly declined by 0.2% [26][28] - The outpatient service revenue contribution increased to 51% from 49% in the first half of the previous year, while inpatient service revenue remained at 50% [31] - The MDA segment saw a significant decline of 12.4%, primarily from Qatar, Kuwait, and Oman, while the Indo-China segment increased by 0.4% [29][30] Market Data and Key Metrics Changes - Middle Eastern business showed strong growth, with Qatar up 18%, UAE up 46%, Oman up 28%, and Saudi Arabia up 54% [5][6] - The company experienced a decline in revenue from Chinese patients, with a drop of over 30% to 40% year-over-year due to safety concerns [65] - The Cambodian market is expected to stabilize, which could improve OPD footfalls and admissions in the future [66] Company Strategy and Development Direction - The company is focusing on expanding its cancer care services, recognizing the growing global cancer crisis and the need for comprehensive care [89][90] - Plans for a new cancer care facility are underway, aimed at enhancing patient experience and integrating advanced technologies [95] - The company is actively negotiating with the Kuwaiti government regarding patient payments and potential future collaborations [39][46] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for Q3 2025, expecting stronger performance compared to the first half of the year [16][25] - The company is cautiously optimistic about the return of Kuwaiti patients, emphasizing the importance of quality care and governance [46][60] - The geopolitical situation in Cambodia and China is impacting patient flow, but management is hopeful for recovery in these markets [66][70] Other Important Information - The company received recognition from Newsweek as one of the best specialized hospitals in Thailand, ranking number one in six out of nine specialties [79] - A successful disease screening campaign generated nearly 96 million baht in revenue within two months [82] - The company upgraded its robotic surgery capabilities, expanding to more specialties and training additional surgeons [84] Q&A Session Summary Question: What is the outlook for the Kuwaiti market? - Management indicated that discussions with Kuwaiti officials are ongoing, and there is cautious optimism about future patient flow and payments [39][46] Question: How is the company addressing the decline in Chinese patients? - The company is expanding its presence in China and engaging in online outreach to improve connections with potential patients [67][68] Question: What are the expectations for the second half of 2025? - Management expects stronger performance in the second half compared to the first half, driven by recovery in key markets [16][25]

Core Viewpoint - Ventas, Inc. is focused on the longevity economy, targeting the growing aging population with strong demand trends, and has improved its outlook for 2025 [2] Company Strategy - The company employs a 123 strategy centered on senior housing (SHOP) to drive multi-year NOI growth, supported by secular demand and limited supply [3] - Ventas has been adding approximately $100 million annually in NOI from inorganic growth, with favorable supply-demand trends expected to persist [3] Financial Outlook - The company anticipates a 7% growth in FFO per share at the midpoint for 2025 [2] - The expected growth rate for the same-store senior housing operating portfolio (SHOP) has been increased to 12% to 16% [2]